Ethyl 3-[3-(2-(methoxyethoxy)carbonyl)ethyl]-6-methyl-4-(3-nitrophenyl)-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate

ID: ALA4095637

PubChem CID: 137653607

Max Phase: Preclinical

Molecular Formula: C20H25N3O8

Molecular Weight: 435.43

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCOC(=O)C1=C(C)NC(=O)N(CCC(=O)OCCOC)C1c1cccc([N+](=O)[O-])c1

Standard InChI:  InChI=1S/C20H25N3O8/c1-4-30-19(25)17-13(2)21-20(26)22(9-8-16(24)31-11-10-29-3)18(17)14-6-5-7-15(12-14)23(27)28/h5-7,12,18H,4,8-11H2,1-3H3,(H,21,26)

Standard InChI Key:  CKRGPBMTWHQHKP-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 31 32  0  0  0  0  0  0  0  0999 V2000
    9.7207  -14.1667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7207  -13.3429    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.0058  -12.9309    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2909  -13.3429    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2909  -14.1667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0058  -14.5786    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.5802  -12.9309    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8653  -13.3429    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.5802  -12.1071    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.4313  -14.5786    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.0058  -12.1071    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7207  -11.6953    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7207  -10.8714    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0058  -10.4595    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2909  -10.8714    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2909  -11.6953    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4313  -10.4595    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.4313   -9.6357    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.1462  -10.8714    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.5802  -14.5786    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4313  -12.9309    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1462  -13.3429    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8610  -12.9309    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8610  -12.1071    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.5718  -13.3429    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.2866  -12.9309    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0015  -13.3429    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7121  -12.9309    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.8653  -11.6953    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8653  -10.8714    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4263  -13.3417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  1  6  1  0
  7  8  2  0
  7  9  1  0
  4  7  1  0
  1 10  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 11 16  2  0
 17 18  2  0
 17 19  1  0
 13 17  1  0
  3 11  1  0
  5 20  1  0
 21 22  1  0
 23 24  2  0
 26 27  1  0
 27 28  1  0
 25 26  1  0
 23 25  1  0
 22 23  1  0
  2 21  1  0
 29 30  1  0
  9 29  1  0
 28 31  1  0
M  CHG  2  17   1  19  -1
M  END

Alternative Forms

  1. Parent:

    ALA4095637

    ---

Associated Targets(Human)

CACNA1H Tclin Voltage-gated T-type calcium channel alpha-1H subunit (1913 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Cacna1c Voltage-gated L-type calcium channel alpha-1C subunit (1321 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 435.43Molecular Weight (Monoisotopic): 435.1642AlogP: 2.08#Rotatable Bonds: 10
Polar Surface Area: 137.31Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: HBA (Lipinski): 11HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.68CX Basic pKa: CX LogP: 1.22CX LogD: 1.22
Aromatic Rings: 1Heavy Atoms: 31QED Weighted: 0.26Np Likeness Score: -1.22

References

1. Teleb M, Zhang FX, Farghaly AM, Aboul Wafa OM, Fronczek FR, Zamponi GW, Fahmy H..  (2017)  Synthesis of new N3-substituted dihydropyrimidine derivatives as L-/T- type calcium channel blockers.,  134  [PMID:28399450] [10.1016/j.ejmech.2017.03.080]

Source